Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Syndax Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Syndax Pharma Raises USD80 Million in Series C Financing 13
Syndax Pharma Raises USD23.9 Million in Venture Financing 15
Syndax Pharma Raises USD4.9 Million in Venture Financing 16
Syndax Pharma Raises US$0.05 Million In Venture Financing 17
Syndax Pharma Raises US$27 Million In Series B Venture Financing 18
Partnerships 20
Syndax Pharma Enters into Agreement with Nektar Therapeutics 20
Syndax Pharma Enters into Agreement with AstraZeneca 21
Syndax Pharma Enters into Agreement with Genentech 22
Syndax Pharma Enters into Co-Development Agreement with National Cancer Institute 23
Merck, Pfizer and Syndax Pharma Enter into Agreement 24
Syndax Pharma Expands its Agreement with Merck 25
Licensing Agreements 26
Syndax Pharma Enters into Licensing Agreement with Vitae Pharma 26
Syndax Pharma Enters into Licensing Agreement with UCB for UCB6352 27
Kyowa Hakko Kirin Amends Licensing Agreement with Syndax Pharma for Entinostat 28
Syndax Pharma Enters into Licensing Agreement with University of Colorado 30
Syndax Pharma Enters Into Licensing Agreement With Eddingpharm For Entinostat 31
Equity Offering 32
Syndax Pharma to Raise USD25 Million in Private Placement of Shares 32
Syndax Pharma Raises USD52.34 Million in Public Offering of Shares 33
Syndax Pharma Completes Underwriters Partial Exercise of Over-Allotment Option of IPO for USD4.9 Million 35
Syndax Pharmaceuticals Inc – Key Competitors 37
Syndax Pharmaceuticals Inc – Key Employees 38
Syndax Pharmaceuticals Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Aug 07, 2018: Syndax Pharmaceuticals reports second quarter 2018 financial results and provides clinical and business update 40
May 08, 2018: Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update 42
Mar 05, 2018: Syndax Pharmaceuticals Announces Fourth Quarter 2017 Financial Results 44
Nov 07, 2017: Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update 46
Aug 10, 2017: Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update 48
May 08, 2017: Syndax Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Clinical and Business Update 50
Mar 02, 2017: Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update 52
Corporate Communications 54
Sep 25, 2018: Syndax Pharmaceuticals announces board changes 54
Apr 04, 2017: Syndax Pharmaceuticals Adds Biopharmaceutical Industry Leader Keith A. Katkin to Board of Directors 55
Feb 09, 2017: Syndax Appoints Richard P. Shea as Chief Financial Officer 56
Jan 05, 2017: Syndax Adds Global Pharmaceutical Business Veteran to Board of Directors 57
Product News 58
11/11/2017: Syndax Announces Presentation of Clinical Trial Data on Drug Candidate SNDX-6352 at Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting 58
11/07/2017: Syndax to Present Data On Drug Candidate SNDX-6352 at SITC 32nd Annual Scientific Meeting 59
Clinical Trials 60
Apr 13, 2018: Syndax to Present On its Menin-MLL1 targeted inhibitor VTP-50469 at the 2018 American Association for Cancer Research Annual Meeting 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Syndax Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Syndax Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Syndax Pharma Raises USD80 Million in Series C Financing 13
Syndax Pharma Raises USD23.9 Million in Venture Financing 15
Syndax Pharma Raises USD4.9 Million in Venture Financing 16
Syndax Pharma Raises US$0.05 Million In Venture Financing 17
Syndax Pharma Raises US$27 Million In Series B Venture Financing 18
Syndax Pharma Enters into Agreement with Nektar Therapeutics 20
Syndax Pharma Enters into Agreement with AstraZeneca 21
Syndax Pharma Enters into Agreement with Genentech 22
Syndax Pharma Enters into Co-Development Agreement with National Cancer Institute 23
Merck, Pfizer and Syndax Pharma Enter into Agreement 24
Syndax Pharma Expands its Agreement with Merck 25
Syndax Pharma Enters into Licensing Agreement with Vitae Pharma 26
Syndax Pharma Enters into Licensing Agreement with UCB for UCB6352 27
Kyowa Hakko Kirin Amends Licensing Agreement with Syndax Pharma for Entinostat 28
Syndax Pharma Enters into Licensing Agreement with University of Colorado 30
Syndax Pharma Enters Into Licensing Agreement With Eddingpharm For Entinostat 31
Syndax Pharma to Raise USD25 Million in Private Placement of Shares 32
Syndax Pharma Raises USD52.34 Million in Public Offering of Shares 33
Syndax Pharma Completes Underwriters Partial Exercise of Over-Allotment Option of IPO for USD4.9 Million 35
Syndax Pharmaceuticals Inc, Key Competitors 37
Syndax Pharmaceuticals Inc, Key Employees 38
Syndax Pharmaceuticals Inc, Other Locations 39
List of Figures
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Syndax Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Syndax Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10